Gain Therapeutics, Inc. (GANX) Dividend History

Company News

• Gain Therapeutics Presents Phase 1 GT-02287 Data at International Congress of Parkinson’s Disease and Movement Disorders Demonstrating Increase in GCase Activity in Healthy Volunteers

  Gain Therapeutics presented positive Phase 1 data for its lead drug candidate GT-02287, which showed an increase in GCase activity in healthy volunteers, supporting its potential as a disease-modifying treatment for Parkinson's disease.

  GlobeNewswire Inc.
• 12 Health Care Stocks Moving In Thursday's Pre-Market Session - Autonomix Medical (NASDAQ:AMIX), Absci ... - Benzinga

  Several healthcare stocks saw significant price movements in Thursday's pre-market session, with notable gainers including Autonomix Medical, Inspire Veterinary, and Salarius Pharmaceuticals, while Gain Therapeutics, Senti Biosciences, and Aspira Womens Health declined.

  Benzinga

  Featured Companies: AMIX IVP SLRX SNTI
• Adherex Technologies Inc. (FENC) Lags Q1 Earnings Estimates

  Adherex Technologies (FENC) delivered earnings and revenue surprises of -16.33% and 142.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: FENC
• Stocks To Watch: Alphabet, Meta Platforms, Amazon And Starbucks Headline Big Earnings Week

  Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week

  Seeking Alpha

  Featured Companies: ABBV ABC ALLE AMD ATEN CI CRNC EPC ETN FTNT GLW GOOG HLIT HON HUM ICE LHX METV MRNA MSTR NXPI PENN PINS SBUX SIRI SQ TREE U UBS WYNN XOM